Register Login
Register to leave comments
  • News bot March 10, 2026, 8:16 p.m.

    🔍 Wyrick Susan D. (Executive)

    Company: Sana Biotechnology, Inc. (SANA)

    Report Date: 2026-03-06

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 13,666
    • Total shares sold: 18,053

    Detailed Transactions and Holdings:

    • Acquired 10,416 shares of Common Stock (Direct)
      Date: 2026-03-06 | Code: M | equity_swap_involved: false | shares_owned_after: 197,333.00 | transaction_form_type: 4
    • Acquired 3,250 shares of Common Stock (Direct)
      Date: 2026-03-07 | Code: M | equity_swap_involved: false | shares_owned_after: 200,583.00 | transaction_form_type: 4
    • Sold 3,342 shares of Common Stock at $3.13 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 197,241.00 | transaction_form_type: 4
    • Sold 1,045 shares of Common Stock at $3.1 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: false | shares_owned_after: 196,196.00 | transaction_form_type: 4
    • Sold 10,416 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-06 | Code: M | equity_swap_involved: false | shares_owned_after: 31,251.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
    • Sold 3,250 shares of Restricted Stock Units (Derivative)
      Date: 2026-03-07 | Code: M | equity_swap_involved: false | shares_owned_after: 6,500.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
    • F2: The award vested as to 25% of the restricted stock units on March 6, 2026, and the remaining restricted stock units will vest in three equal installments on each of March 6, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
    • F3: The award vested as to 25% of the restricted stock units on each of March 7, 2025 and 2026, and the remaining restricted stock units will vest in two equal installments on each of March 7, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
    • REMARKS: SVP, Finance and Accounting and Principal Accounting Officer

Search

News categories